Stock QGEN QIAGEN N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Qiagen N.V.

Equities

QGEN

NL0015001WM6

Real-time Estimate Cboe BZX
Other stock markets
 14:12:14 2024-05-09 EDT 		5-day change 1st Jan Change
43.6 USD +1.55% Intraday chart for Qiagen N.V. +2.23% -2.55%
05-08 Qiagen, US FBI to Jointly Develop Digital PCR Assay for Forensics MT
05-07 QIAGEN Partners with FBI to Develop Digital PCR Assay for QIAcuity for Use in Forensics CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Qiagen, US FBI to Jointly Develop Digital PCR Assay for Forensics
MT
QIAGEN Partners with FBI to Develop Digital PCR Assay for QIAcuity for Use in Forensics
CI
QIAGEN  Announces the Availability of QCI Secondary Analysis
CI
QIAGEN : A decent start to 2024; guidance unchanged
Alphavalue
Qiagen Seeks Acquisitions
CI
Qiagen Q1 Adjusted Earnings, Sales Decline; Q2 Outlook Issued, 2024 Guidance Affirms -- Shares Fall After Hours
MT
Qiagen N.V. Reaffirms Earnings Guidance for the Year 2024
CI
Qiagen N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
QIAGEN N.V. Announces Launch of QIAseq xHYB Mycobacterium Biotechnology Panel for Research Use
CI
Qiagen N.V. Strengthens Its Portfolio for Cancer Research, Showcases Latest Product Launches At AACR Annual Meeting 2024
CI
Mybio Are the New Exclusive Partner for Qiagen in Ireland & Northern Ireland
CI
QIAGEN Introduces QIAstat-Dx Analyzer 2.0 with Remote Test Results Access, Enhancing Collaboration Across Healthcare System
CI
Qiagen Teams Up With Physicians Association for Tuberculosis Screening Program
MT
Volta Labs Partners with OEM by QIAGEN to Unlock Potential of NGS Sample Prep
CI
QIAGEN : In line Q4; routine business prospects remain intact
Alphavalue
Dpa-AFX Overview: COMPANIES from 07.02.2024 - 15:15
DP
Qiagen Q4 Adjusted Earnings, Sales Rise; 2024 Outlook Issued, Shares Slump
MT
Qiagen N.V. Provides Earnings Guidance for Year 2024
CI
Qiagen N.V. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Qiagen N.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QGEN Stock
  4. News Qiagen N.V.
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW